TSC2 and lymphoma: While limited reports have documented a role for mTORC1 in promoting cell survival, knockout of TSC2 and activation of mTORC1 in a mouse model of lymphoma accelerated oncogenesis, suppressed tumor apoptosis, and decreased animal survival in vivo (79).